l 741626 has been researched along with flupenthixol in 2 studies
Studies (l 741626) | Trials (l 741626) | Recent Studies (post-2010) (l 741626) | Studies (flupenthixol) | Trials (flupenthixol) | Recent Studies (post-2010) (flupenthixol) |
---|---|---|---|---|---|
76 | 0 | 33 | 929 | 128 | 138 |
76 | 0 | 33 | 38 | 0 | 18 |
Protein | Taxonomy | l 741626 (IC50) | flupenthixol (IC50) |
---|---|---|---|
Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 7 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 2 | |
D | Rattus norvegicus (Norway rat) | 0.003 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
WD repeat-containing protein 48 | Homo sapiens (human) | 7 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Behnood-Rod, A; Bruijnzeel, AW; Chellian, R; Lin, K; Wilson, R; Wing-Yan King, G | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
2 other study(ies) available for l 741626 and flupenthixol
Article | Year |
---|---|
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats.
Topics: Animals; Conditioning, Operant; Dopamine; Female; Flupenthixol; Locomotion; Male; Nicotine; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2023 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |